| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/03/1986 | EP0193161A2 Antibody hybrid molecules and process for their preparation |
| 09/03/1986 | EP0192811A1 Cysteine-depleted muteins of biologically active proteins, their preparation, formulations containing them, and structural genes, vectors and organisms, and their production, suitable for use in the preparation of said muteins |
| 09/03/1986 | EP0192728A1 Monoclonal antibodies and their use |
| 09/03/1986 | EP0192727A1 Monoclonal antibodies and their use |
| 09/03/1986 | EP0192726A1 Monoclonal antibodies and their use |
| 09/03/1986 | EP0192725A1 Monoclonal antibodies and their use |
| 08/28/1986 | WO1986004922A1 cDNA CODING FOR PLASMODIUM FALCIPARUM GLYCOPHORIN BINDING PROTEINS WEIGHING 130,000 DALTONS AND 155,000 DALTONS |
| 08/27/1986 | EP0192626A1 Malaria vaccine |
| 08/27/1986 | EP0192565A1 Method for the immunological determination of amines, monoclonal antobodies and test kit for carrying out the method |
| 08/20/1986 | EP0191651A2 Method of diagnosing syphilis |
| 08/19/1986 | US4607009 Lewis blood group phenotype assay |
| 08/13/1986 | EP0190185A1 Monoclonal antibodies and their use |
| 08/12/1986 | CA1209500A1 Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
| 08/06/1986 | EP0189688A2 Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis |
| 08/06/1986 | EP0189451A1 Monoclonal antibodies and their use |
| 08/06/1986 | EP0189450A1 Monoclonal antibodies and their use |
| 07/31/1986 | WO1986004420A1 Antibody preparation with specificity for aliphatically bound 4-(2-aminoethyl)imidazolyl group, manufacture and use of the antibody preparation |
| 07/31/1986 | WO1986004356A1 AraB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES |
| 07/30/1986 | EP0188491A1 Monoclonal antibodies and their use |
| 07/23/1986 | EP0187802A1 Monoclonal antibodies and their use |
| 07/23/1986 | EP0187801A1 Monoclonal antibodies and their use |
| 07/17/1986 | WO1986004144A1 Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use |
| 07/16/1986 | EP0187658A2 Method and use for site-specific activation of substances |
| 07/08/1986 | US4599231 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| 07/03/1986 | WO1986003838A1 Monoclonal antibodies and antigen for human non-small cell lung carcinomas |
| 07/02/1986 | EP0186371A2 Monoclonal antibodies specific to antigens of Hepatitis B virus |
| 06/25/1986 | EP0185444A2 Cloning and expression of HTLV-III DNA |
| 06/24/1986 | US4596768 Antibodies for penicilloic acid their preparation and use |
| 06/24/1986 | US4596674 Polypeptides |
| 06/11/1986 | EP0184355A2 Improvements in or relating to a process for purifying proteins |
| 06/11/1986 | EP0183876A1 Monoclonal antibodies for endotoxin core and their use |
| 06/05/1986 | WO1986003223A1 Onco-fetal specific monoclonal antibodies, methods of preparation and use |
| 06/04/1986 | EP0183184A1 Method of cultivating cellular biomaterial and glass fibers with cellular biomaterial or biomaterial |
| 05/28/1986 | EP0182634A2 Diagnostic methods employing antibodies |
| 05/28/1986 | EP0182495A1 Immunoassay means and methods useful in human native prothrombin and human abnormal prothrombin determinations |
| 05/14/1986 | EP0181150A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 05/09/1986 | WO1986002666A1 Methods for protein binding enzyme complementation assays |
| 05/09/1986 | WO1986002650A1 Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides |
| 05/07/1986 | EP0180490A1 Synthetic molecule containing a plurality of distinct epitopes, preparation process and its use in the production of polyvaccines |
| 05/07/1986 | EP0180486A1 Hybrid cells secreting antiidiotypic antibodies, monoclonal antibodies secreted by these hybrid cells, their preparation and their application |
| 05/07/1986 | EP0180171A2 Process for making a targeted cell susceptible to lysis by cytotoxic T lymphocytes |
| 04/30/1986 | EP0179412A2 Antigenic peptide compounds |
| 04/30/1986 | EP0179139A1 Leukemia-associated virus immunogen, vaccine and assay |
| 04/29/1986 | US4585587 Antigenic peptide compounds |
| 04/29/1986 | CA1203762A1 Monoclonal antibodies to cell surface antigens of human renal cancer |
| 04/24/1986 | WO1986002363A1 Monoclonal antibodies and their use |
| 04/24/1986 | WO1986002362A1 Monoclonal antibodies and their use |
| 04/24/1986 | WO1986002361A1 Monoclonal antibodies and their use |
| 04/24/1986 | WO1986002360A1 Monoclonal antibodies and their use |
| 04/24/1986 | WO1986002359A1 Monoclonal antibodies and their use |
| 04/24/1986 | WO1986002356A1 Monoclonal antibodies and their use |
| 04/23/1986 | EP0179023A2 With micro-organisms degradable polypeptide, and its use for the progressive release of medicaments |
| 04/23/1986 | EP0178676A2 Antigenic peptide compounds |
| 04/22/1986 | US4584195 Broad spectrum vaccine against gonorrhea |
| 04/10/1986 | WO1986002080A1 Monoclonal antibodies to cyclosporings |
| 04/10/1986 | WO1986002077A1 Production of streptavidin-like polypeptides |
| 04/09/1986 | EP0176913A2 Glycourethane derivatives, methods for their preparation and their use |
| 04/02/1986 | EP0176493A1 Vaccinal polypeptides |
| 04/02/1986 | EP0176429A1 Compositions and process for protecting T lymphocytes against the etiological agent of lymphadenopathy and an acquired immunodepression syndrom |
| 04/01/1986 | CA1202587A1 Semi-synthetic preparation of human insulin |
| 03/27/1986 | WO1986001808A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001807A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001806A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001805A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001804A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001721A1 Cross-reactive and protective epitopes of circumsporozoite proteins |
| 03/26/1986 | EP0175613A2 Immunogenic hav peptides |
| 03/26/1986 | EP0175577A2 Microchemiluminescent assay system |
| 03/26/1986 | EP0175261A2 Hybrid particle immunogens |
| 03/25/1986 | US4578219 Contraceptive vaccine |
| 03/19/1986 | EP0174805A1 Immunodiagnostic methods |
| 03/19/1986 | EP0174759A1 Multispecific immunogenic proteins |
| 03/13/1986 | WO1986001533A1 Production of chimeric antibodies |
| 03/13/1986 | WO1986001517A1 Herpes virus specific immunological materials and methods |
| 03/05/1986 | EP0173494A2 Chimeric receptors by DNA splicing and expression |
| 03/05/1986 | EP0173280A1 Plasmids containing lambda Pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, hosts containing the plasmids and related methods |
| 02/27/1986 | WO1986001222A1 New hybride cells secreting anti-idiotypic antibodies, new monoclonal antibodies secreted by said hybride cells, preparation and application thereof |
| 02/27/1986 | WO1986001212A1 Minactivin |
| 02/26/1986 | EP0172471A2 Herpes virus specific immunological materials and methods |
| 02/19/1986 | EP0171496A2 Process for the production of a chimera monoclonal antibody |
| 02/13/1986 | WO1986000909A1 Monoclonal antibody directed to human ganglioside gd2 |
| 02/11/1986 | US4569794 Process for purifying proteins and compounds useful in such process |
| 02/05/1986 | EP0170496A2 Vaccine against urinary tract infection |
| 01/30/1986 | WO1986000646A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000645A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000644A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000643A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000642A1 Monoclonal antibodies and their use |
| 01/30/1986 | WO1986000641A1 Monoclonal antibodies and their use |
| 01/29/1986 | EP0169239A1 HUMAN ERYTHROPOIETIN cDNA CLONES |
| 01/22/1986 | EP0168862A2 Biodegradable polymer substrates loaded with active substance suitable for the controlled release of the active substance by means of a membrane |
| 01/21/1986 | CA1199595A1 Coding dna fragments for polypeptids containing at least one antigenic determinant of papillomavirus, specially of type hpv la and corresponding polypeptids |
| 01/15/1986 | EP0167596A1 Anti-idiotype antibodies induced by synthetic polypeptides |
| 01/03/1986 | WO1986000090A1 Hybrid protein and fused gene encoding gene |
| 01/02/1986 | EP0166548A2 Broad spectrum vaccine against gonorrhea |
| 01/02/1986 | EP0166410A2 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
| 01/02/1986 | EP0166233A2 Spherical protein particles with immunoadsorbent properties, and method for their preparation |
| 12/27/1985 | EP0165830A1 Monoclonal antibodies to cytomegalovirus and methods for the diagnosis in vitro of infections by human cytomegaloviruses, using monoclonal antibodies which react with a cytomegalovirus-induced protein kinase |
| 12/27/1985 | EP0165811A2 Sialylated lewis X epitope, antibodies and diagnosis |
| 12/27/1985 | EP0165307A1 Synthetic polypeptide corresponding to a portion of the heat-labile enterotoxin of escherichia coli, compositions and methods therewith |